Controversies in triple negative breast cancer at ESMO19

What should we be watching out for in terms of red and green flags at ESMO on the breast cancer IO front?

September 16, 2019

Novel DDR combinations and regimens that could make a difference

Latest preclinical and clinical news and readouts as well as forthcoming trial presentations to look forward to in the DDR space

August 16, 2019